Minnesota medical device company MetaModix has raised $150,000 in equity between three undisclosed investors, according to a regulatory filing made with the SEC. The startup, which is working to develop an intestinal liner implant as a Type 2 diabetes treatment, still seeks $350,000. The device would be placed while the patient is consciously sedated during […]
The numbers are staggering. The World Health Organization estimates that 346 million people globally live with diabetes. In America alone, the cost of treating the disease was more than $174 billion in 2007, according to the American Diabetes Association. As such, managing the diabetes epidemic is a global priority. Three Minnesota companies are approaching this […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A Minnesota medical device company that aims to treat diabetes in a new way is raising $1.87 million, according to a regulatory filing. MetaModix, which was founded in 2009 to treat metabolic disorders and is developing a minimally invasive approach to treat type 2 diabetes, appears to have already raised half of the money. In […]
Obesity and diabetes are among the most challenging health problems in the United States. MetaModix is developing a minimally invasive alternative to bariatric surgery, which would be an out-patient procedure that would last about 30 minutes.